Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hepatitis C And PrEP Bring More Funding Headaches For NHS England

Executive Summary

Drugs for hepatitis C and HIV prevention are causing funding problems for the NHS in England as court battles loom and innovation continues to bring more cost pressures.


Related Content

English PrEP Study To Use Mylan’s Generic Version Of Gilead’s Truvada
Truvada Sales To Rise On EU Okay In HIV Prevention; UK Use Uncertain
New UK Cancer Drugs Fund Dismays Pharma, Charities
France Leads Europe In Reimbursing Truvada For HIV Prophylaxis
French parliament OKs hep C drug rebate scheme





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts